Clinical Trial Update: Treatment of Children With Kidney Transplants by Injection of CD4+CD25+FoxP3+ T Cells to Prevent Organ Rejection [Phase 1, Phase 2]

View source ↗

Summary

This document reports a Phase 1/2 clinical trial evaluating injections of regulatory T cells (CD4+CD25+FoxP3+ T cells) to prevent organ rejection in children re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease
• Kidney Failure
• Kidney Transplant Rejection

Drugs mentioned

• Regulatory T cell therapy (CD4+CD25+FoxP3+ T cells) (Regulatory T cells)

Snippet

Sponsor: Pirogov Russian National Research Medical University | Conditions: End-Stage Renal Disease, Kidney Failure | Phase 1, Phase 2 | Status: UNKNOWN